| SpectraBase Spectrum ID |
2EVJxYkSrg |
| Name |
1-(2-Dimethylaminoethyl)-4-(3-trifluoromethylbenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
315.192232274 u |
| Formula |
C16H24F3N3 |
| InChI |
InChI=1S/C16H24F3N3/c1-20(2)6-7-21-8-10-22(11-9-21)13-14-4-3-5-15(12-14)16(17,18)19/h3-5,12H,6-11,13H2,1-2H3 |
| InChIKey |
AYOVJAGAYKZHIM-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
315.384 g/mol |
| Nominal Mass |
315 u |
| Quality |
913 |
| Retention Index |
1843 |
| SMILES |
C(C1=CC(CN2CCN(CC2)CCN(C)C)=CC=C1)(F)(F)F |
| SPLASH |
splash10-0a4i-9340000000-f73fb008403abef00218 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-dimethylaminoethyl)-4-(3-trifluoromethylbenzyl)
N,N-dimethyl-2-(4-(3-(trifluoromethyl)benzyl)piperazin-1-yl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011197 |
